Ken Griffin Pluristem Therapeutics Inc Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.18 - $2.18 $56,619 - $104,602
47,983 Added 81.49%
106,868 $131,000
Q1 2022

May 16, 2022
BUY
$1.42 - $2.14 $55,646 - $83,862
39,188 Added 198.95%
58,885 $122,000
Q4 2021

Feb 14, 2022
SELL
$1.46 - $3.1 $56,066 - $119,046
-38,402 Reduced 66.1%
19,697 $28,000
Q3 2021

Nov 15, 2021
SELL
$2.65 - $3.96 $94,575 - $141,328
-35,689 Reduced 38.05%
58,099 $154,000
Q2 2021

Aug 16, 2021
BUY
$3.54 - $4.95 $126,933 - $177,492
35,857 Added 61.9%
93,788 $371,000
Q1 2021

May 17, 2021
BUY
$4.48 - $8.49 $184,576 - $349,788
41,200 Added 246.25%
57,931 $276,000
Q3 2020

Nov 16, 2020
SELL
$8.4 - $11.48 $265,549 - $362,917
-31,613 Reduced 65.39%
16,731 $176,000
Q1 2020

May 15, 2020
BUY
$2.89 - $4.66 $139,714 - $225,283
48,344 New
48,344 $177,000

About PLURISTEM THERAPEUTICS INC

PSTI Quotes by TradingView
  • Ticker PSTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,347,600
  • Market Cap $32.3M
More about PSTI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email